Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

Xu, K; Park, D; Magis, AT; Zhang, J; Zhou, W; Sica, GL; Ramalingam, SS; Curran, WJ; Deng, XM

Deng, XM (reprint author), Emory Univ, Sch Med, Dept Radiat Oncol, Div Canc Biol, Atlanta, GA 30322 USA.; Deng, XM (reprint author), Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.

MOLECULAR CANCER, 2019; 18 ():

Abstract

Background: Lung cancer patients with KRAS mutation(s) have a poor prognosis due in part to the development of resistance to currently available thera......

Full Text Link